GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Longlife Hospital & Research Ltd (BOM:543520) » Definitions » 3-Year EBITDA Growth Rate

Global Longlife Hospital & Research (BOM:543520) 3-Year EBITDA Growth Rate : 8.00% (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Global Longlife Hospital & Research 3-Year EBITDA Growth Rate?

Global Longlife Hospital & Research's EBITDA per Share for the six months ended in Sep. 2023 was ₹2.60.

During the past 12 months, Global Longlife Hospital & Research's average EBITDA Per Share Growth Rate was 51.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Global Longlife Hospital & Research was 8.00% per year. The lowest was 7.30% per year. And the median was 7.65% per year.


Competitive Comparison of Global Longlife Hospital & Research's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Global Longlife Hospital & Research's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Longlife Hospital & Research's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Global Longlife Hospital & Research's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Global Longlife Hospital & Research's 3-Year EBITDA Growth Rate falls into.



Global Longlife Hospital & Research 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Global Longlife Hospital & Research  (BOM:543520) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Global Longlife Hospital & Research 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Global Longlife Hospital & Research's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Longlife Hospital & Research (BOM:543520) Business Description

Traded in Other Exchanges
N/A
Address
Pakwan Cross Road, Near Sindhubhavan Road, Near Water Tank, Opposite Auda Garden, Bodakdev, Ahmedabad, GJ, IND, 380054
Global Longlife Hospital & Research Ltd provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services.

Global Longlife Hospital & Research (BOM:543520) Headlines

No Headlines